Omalizumab may facilitate drug desensitization in patients failing standard protocols

Pediatr Allergy Immunol. 2022 May;33(5):e13783. doi: 10.1111/pai.13783.
No abstract available

Keywords: anaphylaxis; children; drug allergy; drug desensitization; hypersensitivity; nephrotic syndrome; omalizumab.

Publication types

  • Letter

MeSH terms

  • Anaphylaxis*
  • Anti-Allergic Agents* / therapeutic use
  • Desensitization, Immunologic / methods
  • Drug Hypersensitivity* / diagnosis
  • Drug Hypersensitivity* / therapy
  • Humans
  • Omalizumab / therapeutic use

Substances

  • Anti-Allergic Agents
  • Omalizumab